| Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291) |
|---|
| 05/07/2013 | US8435491 Quantification method for remaining liver function and novel liver receptor imaging agent |
| 05/07/2013 | US8435490 Small peptides specifically bind to colorectal cancers |
| 05/07/2013 | US8435489 Non-invasive diagnostic agents of cancer and methods of diagnosing cancer, especially leukemia and lymphoma |
| 05/07/2013 | US8435488 Methods and compositions for protein labelling |
| 05/07/2013 | CA2612187C Stereoselective synthesis of amino acid analogs for tumor imaging |
| 05/07/2013 | CA2564197C Activatable particles, preparations and uses |
| 05/02/2013 | WO2013063312A1 Free psa antibodies as diagnostics, prognostics and therapeutics for prostate cancer |
| 05/02/2013 | WO2013061083A2 Therapeutic agents and uses thereof |
| 05/02/2013 | WO2013060793A1 Bifunctional ligands for radiometals |
| 05/02/2013 | US20130108546 Humanized Antibodies That Recognize Alpha-Synuclein |
| 05/02/2013 | CA2853705A1 Free psa antibodies as diagnostics, prognostics and therapeutics for prostate cancer |
| 05/02/2013 | CA2853669A1 Therapeutic agents and uses thereof |
| 05/02/2013 | CA2850034A1 Therapeutic combinations and methods of treating melanoma |
| 05/01/2013 | CN103080002A Tritiated planar carbon forms |
| 05/01/2013 | CN101709060B F-triazole ring-polyethylene glycol-metronidazole compound and preparation method thereof |
| 04/30/2013 | US8431538 HDAC inhibitors and therapeutic methods of using same |
| 04/30/2013 | US8431537 Glue composition for lung volume reduction |
| 04/30/2013 | US8431359 Nucleotide sequences coding tissue factor pathway inhibitor for use in treatment and prevention of blood disorders |
| 04/30/2013 | CA2730627C Human and mouse targeting peptides identified by phage display |
| 04/25/2013 | WO2013058345A1 Ge adsorbent for 68ge-68ga generator |
| 04/25/2013 | WO2012177624A3 Focused radiation for augmenting immune-based therapies against neoplasms |
| 04/25/2013 | WO2012174285A3 Inhibitor probes for imaging sodium-glucose cotransporters in health and disease |
| 04/25/2013 | WO2012173933A3 Activatable nanoprobes for intracellular drug delivery |
| 04/25/2013 | US20130101510 Methods of treating parkinson's disease using viral vectors |
| 04/25/2013 | US20130101509 Imaging and radiotherapy methods |
| 04/25/2013 | US20130101508 Stabilization of radiopharmaceutical compositions using ascorbic acid |
| 04/25/2013 | US20130101507 Treatment of Renal Cell Carcinoma |
| 04/25/2013 | US20130101505 Stable Activatable Particles as Radiotherapeutic Agents for the Treatment of Disease |
| 04/25/2013 | CA2852897A1 Ge adsorbent for 68ge-68ga generator |
| 04/24/2013 | EP2583966A2 Tricarbonyl technetium-99m or rhenium-188 label ring rgd derivative, a preparation method thereof, and a pharmaceutical composition containing the derivative as an active ingredient for use in the diagnosis or treatment of angiogenesis-related diseases |
| 04/24/2013 | EP2582624A2 Tritiated planar carbon forms |
| 04/24/2013 | CN103068407A Lipophilic cationic probe for pet- imaging |
| 04/24/2013 | CN101951965B Devices for minimally-invasive extraocular delivery of radiation to the posterior portion of the eye and the uses |
| 04/24/2013 | CN101657454B 18 F-labelled folates |
| 04/24/2013 | CN101573143B Fibrin-binding peptides and conjugates thereof |
| 04/24/2013 | CN101305006B Compounds comprising short aminoalcohol chains and metal complexes for medical imaging |
| 04/23/2013 | US8425876 Gene encoding a multidrug resistance human P-glycoprotein homologue on chromosome 7P15-21 and uses thereof |
| 04/23/2013 | US8425459 Medical device rapid drug releasing coatings comprising a therapeutic agent and a contrast agent |
| 04/23/2013 | CA2504818C Anti-cd33 antibodies and method for treatment of acute myeloid leukemia using the same |
| 04/18/2013 | US20130095037 Peptide derivatives of exendin-4 |
| 04/18/2013 | US20130095036 Methods and compositions for diagnosis of iga-and igm-mediated kidney diseases |
| 04/18/2013 | US20130095034 Anti-CD74 Immunoconjugates and Methods |
| 04/18/2013 | US20130095032 Lipidated glycosaminoglycan particles and their use in drug and gene delivery for diagnosis and therapy |
| 04/18/2013 | US20130095031 Isotope production method |
| 04/18/2013 | DE102009055321B4 Verfahren zur Bestimmung der Leberleistung eines Lebewesens mittels quantitativer Messung der Metabolisierung von Substraten A method of determining the liver function of a living being by means of quantitative measurement of the metabolism of substrates |
| 04/18/2013 | CA2852099A1 Meditopes and meditope-binding antibodies and uses thereof |
| 04/17/2013 | EP2581382A2 Radiolabeled compounds and compositions, their precursors and methods for their production |
| 04/17/2013 | EP2579902A1 Method for production of f-18 labeled amyloid beta ligands |
| 04/17/2013 | CN103052406A Bifunctional rho kinase inhibitor compounds, composition And Use |
| 04/17/2013 | CN103041412A PET (Positron Emission Tomography) tracer with FSHR (Follicle-stimulating Hormone Receptor) targeting as well as preparation method and application thereof |
| 04/17/2013 | CN103041411A 99Tcm-Cys-AnnexinV labeled compound with phosphatidylserine as target spot and labeling process and application thereof |
| 04/17/2013 | CN102488909B Application of therapeutic isotope labeled Evans blue and its derivatives in preparing tumor targeted radiotherapy medicaments |
| 04/17/2013 | CN101374555B Methods for measuring the metabolism of neurally derived biomolecules in vivo |
| 04/16/2013 | US8420777 Compounds that inhibit Hsp90 protein-protein interactions with IAP proteins |
| 04/16/2013 | US8420053 Gastrin releasing peptide compounds |
| 04/16/2013 | US8420052 Imaging agents useful for identifying AD pathology |
| 04/16/2013 | US8420050 Gastrin releasing peptide compounds |
| 04/16/2013 | US8420049 Labeled adenosine for use in positron emission tomography |
| 04/16/2013 | CA2491193C Marked maleimide compounds, method for preparing same and use thereof for marking macromolecules |
| 04/16/2013 | CA2490959C Radiolabeled compounds and liposomes and their methods of making and using the same |
| 04/11/2013 | WO2013051778A1 Conjugate having tumor selectivity for targeted treatment |
| 04/11/2013 | WO2013012808A3 System for radiopharmaceutical preparation involving solid and liquid phase interactions |
| 04/11/2013 | US20130090513 Use of boric acid in boron neutron capture therapy for liver cancer |
| 04/11/2013 | US20130089502 Pet radiopharmaceuticals for differential diagnosis between bilateral and unilateral conditions of primary hyperaldosteronism |
| 04/11/2013 | US20130089501 Solid-phase fluorination of benzothiazoles |
| 04/11/2013 | US20130089495 Method for screening size of carrier |
| 04/10/2013 | EP2578237A1 Compositions and methods for enhancing contrast in imaging |
| 04/10/2013 | EP2576520A1 Radiolabeled compounds and methods thereof |
| 04/10/2013 | EP2575900A1 Method for production of f-18 labeled amyloid beta ligands |
| 04/10/2013 | EP2575899A1 Pet radiopharmaceuticals for differential diagnosis between bilateral and unilateral conditions of primary hyperaldosteronism |
| 04/10/2013 | EP2575898A1 Method for production of f-18 labeled amyloid beta ligand |
| 04/10/2013 | EP2575897A2 Crosslinking of proteins and other entities via conjugates of alpha-haloacetophenones, benzyl halides, quinones, and their derivatives |
| 04/10/2013 | CN103028123A Stabalised 99mTc compositions |
| 04/10/2013 | CN102336741B Fluorine-18-marked myocardial perfusion developing agent and preparation method and application thereof |
| 04/10/2013 | CN101222943B Radiolabelled nanoparticles |
| 04/09/2013 | US8415317 Adjuvant compositions and methods for enhancing immune responses to polynucleotide-based vaccines |
| 04/09/2013 | US8415277 Bi-functional compound positively charged at first pH and negatively charged at second pH, solid support comprising the bi-functional compound, and method of isolating nucleic acid using the same |
| 04/09/2013 | US8414885 Methods and compositions for treating cancer |
| 04/09/2013 | US8414864 Gastrin releasing peptide compounds |
| 04/04/2013 | WO2013048996A1 Method for the purification of a peptide-based imaging agent precursor |
| 04/04/2013 | WO2013048832A1 18 f - labelled 6 - ( 2 - fluoroethoxy) - 2 - naphthaldehyde for detecting cancer stem cells |
| 04/04/2013 | WO2013048813A1 Cassette for radiopharmaceutical synthesis |
| 04/04/2013 | WO2013048811A1 Imaging and radiotherapy methods for tumour stem cells |
| 04/04/2013 | WO2013048452A2 Small-molecule tnf modulator to reduce the side effects of chemotherapy and radiotherapy |
| 04/04/2013 | WO2013046163A1 Supramolecular aggregates containing amphiphilic monomers, chelating agents and peptides for use for drug delivery and as contrast agents |
| 04/04/2013 | US20130084289 Treatment of multiple sclerosis |
| 04/04/2013 | US20130084245 Pet monitoring of a-beta-directed immunotherapy |
| 04/04/2013 | US20130084244 Method of differentially diagnosing different types of dementia |
| 04/04/2013 | US20130084242 Combinatorial therapies for the treatment of neoplasias using the opioid growth factor receptor |
| 04/04/2013 | DE102009060317B4 Kontrastmittel zur Verwendung in einem bildgebenden Verfahren zur Diagnose einer metastasierenden Tumorerkrankung und Verfahren zur Abbildung eines metastasierenden Tumorgewebes Contrast agents for use in an imaging method of diagnosing a metastatic tumor and method for imaging a metastatic tumor tissue |
| 04/03/2013 | EP2574347A2 Microspheres comprising therapeutic and diagnostic radioactive isotopes |
| 04/03/2013 | CN103025758A IL-1 binding proteins |
| 04/03/2013 | CN103025357A Compositions and methods for selective delivery of oligonucleotide molecules to specific neuron types |
| 04/03/2013 | CN103007306A Method and application for marking anion-cation type inorganic nano material through samarium-153 and/or lutecium-177 |
| 04/03/2013 | CN101257916B 黑皮质素受体配体 Melanocortin receptor ligands |
| 04/02/2013 | US8410174 Method for treating arthritis |
| 04/02/2013 | US8409547 Radiolabelling methods |
| 03/28/2013 | WO2013042834A1 Radionuclide marked and drug carrying polymer hydrogel and a production method therefor, and pharmaceutical composition for treating cancer comprising same as an active ingredient |
| 03/28/2013 | WO2013042668A1 Radioactive fluorine labeled compound |
| 03/28/2013 | US20130079767 Embolization |